Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder CancerVignesh T. Packiam, Patrick J. Hensley, Joon Kyung Kim et al.|European Urology Oncology|2025Cited by 6